Filing metadata

Accession number
0001683168-21-005869
Form type
Form 4
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
Nov 22, 2021
Reporting period
Nov 19, 2021
Description
Insider transaction

Explore SEC Filings Hub